Clinical Trial Update: Research Study Investigating How Well NNC0174-0833 Works in People Suffering From Overweight or Obesity. [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated the efficacy and safety of NNC0174-0833 in adults with overweight or obesity; the study has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• NNC0174-0833

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Overweight, Obesity | Phase 2 | Status: COMPLETED | Results posted: 2023-07-18